Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Cash-Flows-Other-Operating" stands at -4.50 Billion Swiss Francs for the trailing twelve months (TTM) period ending 09/30/2024, the lowest value since 06/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -3.61 Billion Swiss Francs compared to the value the year prior.
The 1 year change is -3.61 Billion Swiss Francs.
The 3 year change is 6.24 Billion Swiss Francs.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Flows Other Operating | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Flows Other Operating | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Flows Other Operating | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Cash Flows Other Operating | 280,205,508,085.11 |
![]() | Novartis AG - Cash Flows Other Operating | 255,096,620,580.91 |